Anti-inflammatory Effects of Colchicine in PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.
Also called NCT01709981
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 280 participants
- Sponsor
- Registry
-
NCT01709981
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01709981. Randomized; quadruple masking; primary purpose treatment. Start 2013-05-30 (actual); primary completion 2019-08-30 (actual). Results posted on 2020-09-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anti-inflammatory Effects of Colchicine in PCI
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo
- Lead sponsor
- NYU Langone Health
- Collaborator
- Takeda
Record details
- Record id
cardio:ct-nct01709981- Content hash
4e17635fe673b5257b0b44568c9ae7bc0648ad8a49bcb5a85412f139f0ae2255